TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: S-Klotho levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: miR-499
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cfDNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exosomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fetal Health
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Anxiety Level of the Pregnant
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Swanson, Nolan and Pelham Chinese (SNAP) rating scales
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conners' Continuous Performance Test 3rd Edition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quantitative electroencephalogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Ohio Autism Clinical Global Impression Scale - Severity (OACIS-S)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone regeneration level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Strength of anteflexors in I position
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Strength of anteflexors in Y position
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Strength of anteflexors in T position
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: EMG activity of upper trapezius
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: EMG activity of lower trapezius
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Ultrasonography confirmation success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biomarkers associated with immune efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: RP2D
Endpoint domain: Adverse events/effects
Primary endpoint: Gastric-half emptying time of the 75 g glucose drink
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of severe bleeding during ECMO
Endpoint domain: Adverse events/effects
Primary endpoint: IUS CD activity index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arylsulfatase A (ARSA) activity levels in Cerebrospinal Fluid (CSF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuronal metabolite ratio of N-acetyl-aspartate (NAA) to creatine (Cr)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spatial correlation of hypoxic tumour volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feelings and concerns regarding treatment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Hamilton Anxiety Rating Scale total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in HbA1c%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of G6PD deficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Help Seeking Behavior
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Assured NEN diagnosis of the BPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assured NEN diagnosis of the GEPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain at the start of the active phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anxiety at the start of the active phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: birth perception in the postpartum period
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of patients receiving effective antibiotic therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Disease activity assessed by SLEDAI-2K
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease activity assessed by Physician Global Assessment (PGA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of each microstate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of each microstate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global explained variance (GEV) of each microstate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cleanliness of gastric mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Strength assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Antibody response to SARS-CoV-2 S protein after 2 doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Antibody response to SARS-CoV-2 S protein after 3 doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Antibody response to SARS-CoV-2 S protein after 4 doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of perioperative hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Satisfactory relief of pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: tuberculosis transmission
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: contact case tracking
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Validity of Thai version of Kamath and Stothard Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reliability of Thai version of Kamath and Stothard Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patients' acceptance of diabetic retinopathy screenings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 5-point Subject Global Aesthetic Improvement Scale (SGAIS) for skin laxity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Degree of inflammation in acute lung injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in empathy towards smokers
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in self-efficacy towards smoking cessation counseling
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of adverse events (AEs) defined as dose-limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerable dose (MTD) based on incidence of dose-limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Recommended Phase 2 dose (RP2D) based on incidence of dose-limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Time to resolution of post-operative ileus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Risk of Postpartum haemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Willingness to seek treatment for knee osteoarthritis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Exclusive breastfeeding rate at 4 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Management of adverse events related to adjuvant hormone therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity of the PPG-based WHOOP ANF algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Specificity of the PPG-based WHOOP ANF algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Spirometric measurements (Forced vital capacity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Muscle strength measurements (skeletal muscles)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in Emotion Regulation Difficulties
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to onset of disease progression
Endpoint domain: Mortality/survival
Primary endpoint: Pain outcome measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Joint stiffness and function measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Overall symptom assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Electrophysiological scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: safety of Abciximab
Endpoint domain: Adverse events/effects
Primary endpoint: Days at Home
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Mean High resolution CT (HRCT) fibrosis scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart-rate variability (HRV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Efficacy of extinction learning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: active range of motion in shoulder joint, elbow, wrist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in errors by caregivers
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Airway resistance through oscillometry test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Asthma Flare-up diary
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CASI questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in gut microbiota characterization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in gut microbiota diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the iAUC for ghrelin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in astigmatism management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in King´s Parkinson´s Disease Pain Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Brief Pain Inventory score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Temporal Summation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Pain Pressure Threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child Health Index
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Nociception level (NoL) index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of urethral reconstructive surgeries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Modification of the number of visits to hospital centers
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Modification of emergency consultations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Modification of falls, sores and infections
Endpoint domain: Adverse events/effects
Primary endpoint: Change in composite YBT-LQ scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: toxicity/tolerability
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline Blood Pressure at 16 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from Lipid Profile at 16 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Quality of Life Perception at 16 weeks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subjective Continence Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of life as assessed by Kansas City Cardiomyopathy Questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Child's birth and survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Natural-log-transformed low frequency power of pulse wave transit time variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Center of Gravity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Ivabradine-induced Atrial Fibrillation (AF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in BCVA value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the thickness of the macular fovea (CRT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numbers of clinical features of eclampsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intraoperative bleeding characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in modified respiratory severity score (mRSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Severe Adverse Event (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportions of Double Burden of Malnutrition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Liver proton density fat fraction (PDFF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Inventory of Depressive Symptomatology-Self Report (IDS-SR)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Preference for music program over standard program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Thermoregulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stress (enzyme linked immunoassays)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sweat Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative morphine consumption within the first 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative visual analogue scale (VAS) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of all-cause death and serious complications of AF therapy
Endpoint domain: Mortality/survival
Primary endpoint: Remote monitoring efficiency
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in documented infection with COVID-19
Endpoint domain: Adverse events/effects
Primary endpoint: Hopkins Rehabilitation Engagement Rating Scale-HRERS
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of Shoulder Pain and Disability Index (SPADI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Glycosylated hemoglobin A1c (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Success Rate of the Graded Amoxicillin Challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relief of itching associated with chickenpox
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum level of TWEAK
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: World Health Organization (WHO) motor milestone change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hammersmith Infant Neurological Examination-2 (HINE-2) scale score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor function evaluation-Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND) scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor function evaluation-Hammersmith Functional Motor Scale-Expanded (HFMSE) scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor function evaluation-Revised Upper Limb Module (RULM) scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abdominal Pain Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent drug use days
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Dose-limiting Toxicities Incidence Count
Endpoint domain: Adverse events/effects
Primary endpoint: Sprint Power Output
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Vascular Dementia Assessment Scale-cognitive subscale (VADAS-cog)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: limitation of physical alteration before surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Height of displacement of a skin disc
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Perceived self-efficacy of nurses
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total score on the Suitability Evaluation Questionnaire (SEQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Measurement of protein S
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Measurement of antithrombin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Search for lupus anticoagulants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of collapsed units on EIT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scoring on a specific musical questionnaire for adults: MuMu
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Scoring on a specific musical questionnaire for adults: MuRQoL
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Score on a questionnaire for individuals aged 6-17 years
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Score obtained in the discovery level with the Meludia music tool
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in voice quality of CI users compared with their normal hearing control peers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of encephalopathic features in newborn infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Toronto Rehabilitation Institute Hand Function Test (TRI-HFT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Graded and Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP), v2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grasp and Release Test (GRT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of the predictive model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gut microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: load bearing over the affected lower limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality/symmetry of gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: level of ambulation and physical independence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of participants with significant laboratory abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Quantitative CT Scoring for Pathological Accumulations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitative Ultrasound Scoring for Pathological Accumulations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative varicose veins sequelae
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Causality of treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the concentration-versus-time curve (AUC) from time zero to the last measurable plasma concentration (AUClast) of TNO155
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum (peak) observed plasma concentration (Cmax) of TNO155
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elimination half-life (T1/2) of TNO155
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Error Related Negativity (ERN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes